After Covid-19 Vaccines, What Else Can mRNA Tech Do?
WSJ Tech News Briefing - A podcast by The Wall Street Journal
The Covid-19 vaccines from Pfizer and Moderna were the first products using mRNA tech to get approved for use. Now scientists and researchers are looking at other uses for that tech, such as more effective flu vaccines or creating the first effective HIV vaccine. Health reporter Jared S. Hopkins joins host Zoe Thomas to discuss where this health tech could be headed next. Learn more about your ad choices. Visit megaphone.fm/adchoices
